ABCB1 and osteosarcoma: Several studies have proposed a mechanism of drug resistance using HDACi agents for osteosarcoma in which the multidrug resistance protein 1 (MDR1) encoded by the ABCB1 gene is upregulated in doxorubicin-resistant OS cells, which are also resistant to HDACi agents [80,82].